Perioperative management of antiplatelet therapy

Slides:



Advertisements
Similar presentations
Ticlopidine (Ticlid™) and Clopidogrel (Plavix™) Benedict R. Lucchesi, M.D., Ph.D. Department of Pharmacology University of Michigan Medical School.
Advertisements

ANTIPLATELET DRUGS.
ANTIPLATELET DRUGS Learning objectives By the end of this lecture, students should be able to: - describe different classes of anti-platelet drugs and.
Usefulness of Platelet Response to Clopidogrel by Point-of-Care Testing to Predict Bleeding Outcomes in Patients Undergoing Percutaneous Coronary Intervention.
II. Antiplatelet Drugs.
Volume 124, Issue 2, Pages (June 2009)
Volume 124, Issue 2, Pages (June 2009)
Algorithm for preoperative management of patients taking antiplatelet therapy. ACS, acute coronary syndrome; BMS, bare metal stent; DES, drug-eluting stent;
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
Long-term clinical outcome of elderly patients with acute coronary syndrome treated with early percutaneous coronary intervention: Insights from the BASE.
Aspirin and Clopidogrel Resistance
Mandeep Singh, MD, MPH, Deepak L. Bhatt, MD, MPH, Gregg W
B.D. Woods, R.N. Sladen  British Journal of Anaesthesia 
Robert A. Guyton, MD  The Annals of Thoracic Surgery 
New antiplatelet drugs and new oral anticoagulants
Volume 55, Issue 6, Pages (December 2011)
Aspirin and Clopidogrel Resistance
P Barash, S Akhtar  British Journal of Anaesthesia 
Sevoflurane therapy for life-threatening asthma in children
2016 ACC/AHA guideline focused update on duration of dual antiplatelet therapy in patients with coronary artery disease  Glenn N. Levine, MD, FACC, FAHA,
Why is the surgical high-risk patient still at risk?
Gregg W. Stone, MD, Herbert D. Aronow, MD, MPH  Mayo Clinic Proceedings 
P. Foëx  British Journal of Anaesthesia 
C-reactive protein and coronary events following percutaneous coronary angioplasty  Robbert J de Winter, MD, PhD, Karel T Koch, MD, PhD, Jan P van Straalen,
Characteristics of pain in hospitalized medical patients, surgical patients, and outpatients attending a pain management centre  M.P. Rockett, G. Simpson,
J. Trevor Posenau, MD, Daniel M. Wojdyla, MS, Linda K
Parkinson's disease and anaesthesia
Perioperative antiplatelet therapy: the case for continuing therapy in patients at risk of myocardial infarction  P.-G. Chassot, A. Delabays, D.R. Spahn 
R.S. Vela Vásquez, R. Peláez Romero  British Journal of Anaesthesia 
Factors Influencing Mortality After Emergency Coronary Artery Bypass Grafting for Failed Percutaneous Transluminal Coronary Angioplasty  Harold L Lazar,
Perioperative factor concentrate therapy
Perioperative statin therapy in patients at high risk for cardiovascular morbidity undergoing surgery: a review  B.A. de Waal, M.P. Buise, A.A.J. van.
Tornado diagram of one-way deterministic sensitivity analysis.
Figure 1 Potential interactions between aspirin, P2Y12 inhibitors, and proton pump inhibitors in patients ... Figure 1 Potential interactions between aspirin,
Assessment of platelet inhibition secondary to clopidogrel and aspirin therapy in preoperative acute surgical patients measured by Thrombelastography®
Perioperative bradycardia and asystole: relationship to vasovagal syncope and the Bezold–Jarisch reflex  S.M. Kinsella, J.P. Tuckey  British Journal of.
M.E. Stone, B. Salter, A. Fischer  British Journal of Anaesthesia 
Acupuncture for treatment of therapy-resistant post-dural puncture headache: a retrospective case series  J. Dietzel, T. Witstruck, S. Adler, T.I. Usichenko 
Inflating LMA with normal saline: 14 yr after
Volume 81, Issue 12, Pages (June 2012)
Multimodal therapies for postoperative nausea and vomiting, and pain
T Emerick, D Metro, R Patel, T Sakai  British Journal of Anaesthesia 
Effect of preoperative P2Y12 and thrombin platelet receptor inhibition on bleeding after cardiac surgery  M. Ranucci, D. Colella, E. Baryshnikova, U.
Update on massive transfusion
Preoperative evaluation of patients with, or at risk of, coronary artery disease undergoing non-cardiac surgery  P.-G. Chassot, A. Delabays, D.R. Spahn 
Meta-analysis of the effect of heart rate achieved by perioperative beta-adrenergic blockade on cardiovascular outcomes  B.M. Biccard, J.W. Sear, P. Foëx 
Markov model scheme. Markov model scheme. Patients start (state 0) with uncomplicated PCI revascularisation; then cycle between health states until death.
H. T. Benzon, R. J. McCarthy, H. A. Benzon, M. C. Kendall, S. Robak, P
DuyKhanh P. Ceppa, MD, Ian J. Welsby, MBBS, Tracy Y. Wang, MD, Mark W
C. Price, J. Lee, A.M. Taylor, A.P. Baranowski 
II. Should anaesthetists stop infusing isotonic saline?
New oral anticoagulants and regional anaesthesia
Efficacy of dexmedetomidine compared with midazolam for sedation in adult intensive care patients: a systematic review  R. Adams, G.T. Brown, M. Davidson,
Aged erythrocytes: a fine wine or sour grapes?
From Primary to Secondary Percutaneous Coronary Intervention: The Emerging Concept of Early Mechanical Reperfusion With Delayed Facilitated Stenting—When.
Neurological biomarkers in the perioperative period
J Lee, S Gupta, C Price, A.P. Baranowski 
Chronic widespread pain, including fibromyalgia: a pathway for care developed by the British Pain Society  J. Lee, B. Ellis, C. Price, A.P. Baranowski 
A. Hofer, S. Kozek-Langenecker, E. Schaden, M. Panholzer, H. Gombotz 
Pharmacological perioperative brain neuroprotection: a qualitative review of randomized clinical trials  F. Bilotta, A.W. Gelb, E. Stazi, L. Titi, F.P.
S. Radhakrishna  British Journal of Anaesthesia 
International practices of organ donation
IV. History of anaesthesia in Colombia: periods of development
Guy S. Reeder, M.D., Raymond J. Gibbons, M.D.  Mayo Clinic Proceedings 
Intraoperative use of ketorolac or diclofenac is associated with improved disease-free survival and overall survival in conservative breast cancer surgery 
Minimally invasive direct coronary artery bypass, percutaneous transluminal coronary angioplasty, and stent placement for left main stenosis  William.
Effect of concentration of local anaesthetic solution on the ED50 of bupivacaine for supraclavicular brachial plexus block†   P.K. Gupta, P.M. Hopkins 
P2Y12 receptor inhibitor therapy for secondary prevention of patients with stable coronary artery disease. P2Y12 receptor inhibitor therapy for secondary.
Demoule A. , Lefort Y. , Lopes M.-E. , Lemaire F.  
R. Parke, S. McGuinness, R. Dixon, A. Jull 
Presentation transcript:

Perioperative management of antiplatelet therapy A.D. Oprea, W.M. Popescu  British Journal of Anaesthesia  Volume 111, Pages i3-i17 (December 2013) DOI: 10.1093/bja/aet402 Copyright © 2013 The Author(s) Terms and Conditions

Fig 1 Therapies targeted at inhibiting various platelet receptors. These include the thromboxane inhibitors, ADP receptor antagonists, and GPIIb/IIIa inhibitors. Adapted from Meadows and Bhatt,4 with permission. TxA2, thromboxane A2; GP Ia/IIa, glycoprotein Ia/IIa; GP VI, glycoprotein VI; GP Ib-IX-V, glycoprotein Ib-IX-V; ADP, adenosine diphosphate; GP IIb/IIIa, glycoprotein IIb/IIIa. British Journal of Anaesthesia 2013 111, i3-i17DOI: (10.1093/bja/aet402) Copyright © 2013 The Author(s) Terms and Conditions

Fig 2 Algorithm for perioperative management of antiplatelet therapy. Adapted from Di Minno and colleagues,99 with permission. ADP, adenosine diphosphate; ASA, aspirin; PTCA, percutaneous transluminal coronary angioplasty; BMS, bare metal stent; DES, drug-eluting stent; MI, myocardial infarction; ST, stent thrombosis. British Journal of Anaesthesia 2013 111, i3-i17DOI: (10.1093/bja/aet402) Copyright © 2013 The Author(s) Terms and Conditions